Randomized control trial of effect of cholesterol absorption with ischemic heart disease patients.
Not Applicable
- Conditions
- Ischemic heart disease.
- Registration Number
- JPRN-UMIN000002297
- Lead Sponsor
- Kameda General Hospital, department of cardiology.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who treated with insulin therapy. 2. HbA1c over 9%. 3. Patients who diagnosed of acute coronary syndrome in one month. 4. Patients who had history of anaphylaxis to the ezetimibe or atorvastatin. 5. AST over 100 IU/l or 127 IU/l. 6. Patients with secondary hyperlipidemia of drug-induced hyperlipidemia. 7. Patients who is pregnant or lactating. 8. Familial hyperlipidemia. 9. Other conditions precluding participation as judged by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent change of endothelial function.
- Secondary Outcome Measures
Name Time Method Comparison between two groups of serum lipid profile, adipocytokine, oxidative-stress and inframmatory marker, expression frequency of adverse effect due to the drugs.